4.7 Article

α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss

Journal

JOURNAL OF NEUROSCIENCE
Volume 41, Issue 10, Pages 2264-2273

Publisher

SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.1871-20.2020

Keywords

alpha-synuclein oligomers; astrocytic glutamate; extrasynaptic NMDARs; synaptic damage

Categories

Funding

  1. NIA NIH HHS [R01 AG056259, RF1 AG057409, R00 AG050764, R56 AG065372, K99 AG050764] Funding Source: Medline
  2. NIDA NIH HHS [DP1 DA041722, R01 DA048882] Funding Source: Medline
  3. NINDS NIH HHS [R01 NS086890] Funding Source: Medline

Ask authors/readers for more resources

In Parkinson's disease, synaptic and neuronal loss are prominent features. The study reveals that alpha Syn oligomers induce excessive glutamate release from astrocytes, activating NMDARs on neurons and leading to synaptic damage. However, the drug NitroSynapsin shows promise in protecting synapses from alpha Syn-induced damage.
Synaptic and neuronal loss are major neuropathological characteristics of Parkinson's disease. Misfolded protein aggregates in the form of Lewy bodies, comprised mainly of alpha-synuclein (alpha Syn), are associated with disease progression, and have also been linked to other neurodegenerative diseases, including Lewy body dementia, Alzheimer's disease, and frontotemporal dementia. However, the effects of alpha Syn and its mechanism of synaptic damage remain incompletely understood. Here, we show that alpha Syn oligomers induce Ca2+-dependent release of glutamate from astrocytes obtained from male and female mice, and that mice overexpressing alpha Syn manifest increased tonic release of glutamate in vivo. In turn, this extracellular glutamate activates glutamate receptors, including extrasynaptic NMDARs (eNMDARs), on neurons both in culture and in hippocampal slices of alpha Syn-overexpressing mice. Additionally, in patch-clamp recording from outside-out patches, we found that oligomerized alpha Syn can directly activate eNMDARs. In organotypic slices, oligomeric alpha Syn induces eNMDAR-mediated synaptic loss, which can be reversed by the drug NitroSynapsin. When we expose human induced pluripotent stem cell-derived cerebrocortical neurons to alpha Syn, we find similar effects. Importantly, the improved NMDAR antagonist NitroSynapsin, which selectively inhibits extrasynaptic over physiological synaptic NMDAR activity, protects synapses from oligomeric alpha Syn-induced damage in our model systems, thus meriting further study for its therapeutic potential.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available